Is UNH a good stock to buy? We came across a bullish thesis on UnitedHealth Group Incorporated on r/ValueInvesting by ContributionKindly13. In this article, we will summarize the bulls’ thesis on UNH. UnitedHealth Group Incorporated’s share was trading at $388.47 as of May 25th. UNH’s trailing and forward P/E were 29.25 and 21.28 respectively according to Yahoo Finance.
alexkich/Shutterstock.com
UnitedHealth Group Incorporated operates as a health care company in the United States and internationally. UNH reported its Q1 2026 results, marking a clear inflection point in operational performance as the company continues recovering from the 2024 trough driven by the Change Healthcare cyberattack and non-recurring disruptions. Instead of relying on narrative framing, the results highlight measurable improvement in earnings power and underwriting discipline across the core businesses.
Read More: 15 AI Stocks That Are Quietly Making Investors Rich
Read More: Undervalued AI Stock Poised For Massive Gains: 10000% Upside Potential
The EPS trajectory underscores the rebound, with 2023 EPS at $23.86, a depressed $15.51 in 2024, and FY 2026 guidance now set above $18.25, signaling stabilization and gradual normalization. In Q1 2026, the company delivered EPS of $7.23, beating consensus expectations of $6.59, while revenue came in at $111.7B, exceeding the $109.44B forecast and reinforcing steady top-line resilience. The most important driver of the beat was Medical Care Ratio (MCR) improvement, which declined from 84.8% in Q1 2025 to 83.9% in Q1 2026, reflecting stronger cost containment and pricing discipline in the insurance segment.
This 90-basis-point improvement demonstrates that margin recovery is being driven by execution rather than one-off revenue gains or accounting effects. As a result, management raised full-year 2026 guidance above $18.25, reinforcing confidence in sustained earnings momentum.
With MCR trends stabilizing below 84%, UnitedHealth Group appears well-positioned to deliver durable earnings growth and potentially support a continued re-rating as the market prices in improved visibility and reduced operational risk. With disciplined medical cost management and improving utilization dynamics supporting margins, the earnings base appears increasingly sustainable and less volatile than prior year expectations, strengthening long-term investor confidence in the business model overall.
Previously, we covered a bullish thesis on UnitedHealth Group Incorporated (UNH) by FluentInQuality’s Substack in May 2025, which highlighted its vertically integrated moat, Optum scale, and long-term healthcare tailwinds. UNH’s stock price has appreciated by approximately 31.68% since our coverage. ContributionKindly13 shares a similar view but emphasizes Q1 2026 earnings inflection, MCR improvement, and FY2026 guidance above $18.25, focusing on margin-led recovery.
UnitedHealth Group Incorporated is on our list of the 40 Most Popular Stocks Among Hedge Funds. As per our database, 145 hedge fund portfolios held UNH at the end of the fourth quarter which was 140 in the previous quarter. While we acknowledge the risk and potential of UNH as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and doing so within a shorter time frame. If you are looking for an AI stock that is more promising than UNH and that has 10,000% upside potential, check out our report about this cheapest AI stock.
Disclosure: None.
